monitoring of human cytomegalovirus and virus-specific t-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation监测人类巨细胞病毒和病毒特异性t细胞反应年轻接受同种异体造血干细胞移植的病人.pdfVIP

monitoring of human cytomegalovirus and virus-specific t-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation监测人类巨细胞病毒和病毒特异性t细胞反应年轻接受同种异体造血干细胞移植的病人.pdf

  1. 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
monitoring of human cytomegalovirus and virus-specific t-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation监测人类巨细胞病毒和病毒特异性t细胞反应年轻接受同种异体造血干细胞移植的病人

Monitoring of Human Cytomegalovirus and Virus- Specific T-Cell Response in Young Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation 1 1 2 2 2 Daniele Lilleri , Giuseppe Gerna *, Paola Zelini , Antonella Chiesa , Vanina Rognoni , 3 4 4 3,5 Angela Mastronuzzi , Giovanna Giorgiani , Marco Zecca , Franco Locatelli 1 Laboratori Sperimentali di Ricerca, Area Trapiantologica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 2 Struttura Semplice Virologia Molecolare, Struttura Complessa Virologia e Microbiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 3 Dipartimento di Oncoematologia Pediatrica, IRCCS Ospedale Pediatrico ` ` Bambino Gesu, Roma, Italy, 4 Struttura Complessa di Ematologia ed Oncologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 5 Universita di Pavia, Pavia, Italy Abstract In allogeneic hematopoietic stem-cell transplantation (HSCT) recipients, outcome of human cytomegalovirus (HCMV) infection results from balance between viral load/replication and pathogen-specific T-cell response. Using a cut-off of 30,000 HCMV DNA copies/ml blood for pre-emptive therapy and cut-offs of 1 and 3 virus-specific CD4+ and CD8+ T cells/ml blood for T-cell protection, we conducted in 131 young patients a prospective 3-year study aimed at verifying whether achievement of such immunological cut-offs protects from HCMV disease. In the first three months after transplantatio

您可能关注的文档

文档评论(0)

hello118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档